The Effect of Epidural Steroid Injections on Glycemic Control in Diabetic Patients According to the Doses of Steroids
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01435707 |
Recruitment Status :
Completed
First Posted : September 19, 2011
Last Update Posted : December 25, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Low Back Pain | Other: epidural steroid injection with Triamcinolone 40mg Other: Selective transforaminal epidural block with triamcinolone 20 mg Other: caudal epidural steroid injection with Triamcinolone 20mg Other: Selective transforaminal epidural block with triamcinolone 40 mg | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 125 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Official Title: | The Effect of Epidural Steroid Injections on Glycemic Control in Diabetic Patients According to the Doses of Steroids |
Study Start Date : | September 2011 |
Actual Primary Completion Date : | March 2013 |
Actual Study Completion Date : | March 2013 |

Arm | Intervention/treatment |
---|---|
Experimental: Caudal 40 group
subjects who undergo caudal epidural block with triamcinolone 40 mg
|
Other: epidural steroid injection with Triamcinolone 40mg
epidural steroid injection with Triamcinolone 40mg
Other Names:
|
Experimental: STE 20 group
subjects who undergo selective transforaminal block with triamcinolone 20 mg
|
Other: Selective transforaminal epidural block with triamcinolone 20 mg
Selective transforaminal epidural block with triamcinolone 20 mg
Other Names:
|
Experimental: Caudal 20 mg
subjects who undergo caudal epidural block with triamcinolone 20 mg
|
Other: caudal epidural steroid injection with Triamcinolone 20mg
caudal epidural steroid injection with Triamcinolone 20mg
Other Names:
|
Experimental: STE 40 group
subjects who undergo selective transforaminal block with triamcinolone 40 mg
|
Other: Selective transforaminal epidural block with triamcinolone 40 mg
Selective transforaminal epidural block with triamcinolone 40 mg
Other Names:
|
- fasting blood glucose level [ Time Frame: at 7:00 am of postprocedure day 1 ]before breakfast (fasting state)
- fasting blood glucose level [ Time Frame: at 7:00 am of postprocedure day 2 ]before breakfast (fasting state)
- fasting blood glucose level [ Time Frame: at 7:00 am of postprocedure day 3 ]
- fasting blood glucose level [ Time Frame: at 7:00 am of postprocedure day 4 ]
- fasting blood glucose level [ Time Frame: at 7:00 am of postprocedure day 5 ]
- fasting blood glucose level [ Time Frame: at 7:00 am of postprocedure day 6 ]
- fasting blood glucose level [ Time Frame: at 7:00 am of postprocedure day 7 ]
- fasting blood glucose [ Time Frame: at 7:00 am of postprocedure day 14 ]
- post-prandial glucose level [ Time Frame: 2 hour after dinner at postprandial day 1, 2, 3, 4, 5, 6, 7, 14 ]2 hour after dinner
- visual analogue scale of subjective pain [ Time Frame: at 7 p.m. of postprocedure day 1, 2, 3, 4, 5, 6, 7, 14 ]at 7:00 am of postprocedure day 5

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- subjects who undergo epidural steroid injection (caudal epidural injection or selective transforaminal block) in the pain medicine outpatient clinic
- subjects older than 20 yrs.
Exclusion Criteria:
- ASA (American society of Anesthesiologists class) III or more
- severe cardiopulmonary disease or brain disorder
- Subjects diagnosed uncontrolled diabetes with complications
- subjects undergoing hormone therapy
- subjects with active infection
- subjects with pregnancy
- subjects with recent stress condition such as surgery or trauma
- subjects with active neurologic disorder
- those with anticoagulation therapy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01435707
Korea, Republic of | |
Samsung Medical Center | |
Seoul, Korea, Republic of, 135-710 |
Responsible Party: | Woo Seog Sim, Associate Professor, Samsung Medical Center |
ClinicalTrials.gov Identifier: | NCT01435707 |
Other Study ID Numbers: |
2011-08-058 |
First Posted: | September 19, 2011 Key Record Dates |
Last Update Posted: | December 25, 2013 |
Last Verified: | December 2013 |
epidural steroid injection triamcinolone fasting blood glucose diabetes mellitus |
Low Back Pain Back Pain Pain Neurologic Manifestations Triamcinolone Triamcinolone Acetonide Triamcinolone hexacetonide Triamcinolone diacetate Anti-Inflammatory Agents |
Glucocorticoids Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs Immunosuppressive Agents Immunologic Factors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |